Company / SG&A per Share
Decoy Therapeutics Inc. SG&A per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$3.37
FY2022
5-year range
$0.26 / $3.37
FY2018-FY2022
Trend
+1215.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share changed +1215% YoY in FY2022, a notable deviation from the 6-year average annual change of +247%.
Based on SEC 10-K filings.
3.37 in FY2022 with a 5-year CAGR of +28.0%.
Increased from $1.71 to $3.37 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +42.9%
- 5-Year CAGR
- +28.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, sg&a per share increased 1215.4% year-over-year.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $3.37 | +1215.4% |
| FY2021 | $0.26 | -85.0% |
| FY2020 | $1.71 | +48.0% |
| FY2019 | $1.16 | +3.5% |
| FY2018 | $1.12 | +13.7% |
| FY2017 | $0.98 | +283.8% |
| FY2016 | $0.26 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026